Results 71 to 80 of about 21,002 (228)

Artificial Intelligence‐Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions

Orthopaedic Surgery, EarlyView.
This comprehensive review integrates 17 benchmark studies to illustrate the transition of osteoporosis management toward precision medicine. The schematic highlights three key clinical applications: AI‐driven opportunistic screening from routine CTs, precision pharmacotherapy selection, and the predictive prevention of adverse events like MRONJ ...
Xiang Yao, Yicong Chao, Xiao Gu, Jingtao Peng, Jishan Yuan, Wei Shi, Fuguo Zhang, Qiwen Bao   +7 more
wiley   +1 more source

Implications of Pharmacoeconomics for Iran National Health System: Implications of Pharmacoeconomics for Iran National Health System

, 2013
Like many other developing countries pharmacoeconomics and outcome research and its applications in national health system is a new but promising filed in Iran.
Abdol Majid Cheraghali
core   +1 more source

Budget impact of implementing universal Plasmodium NAT screening in the blood transfusion system in the US

Transfusion, EarlyView.
Abstract Background Blood donor deferral for malaria risk relies exclusively on responses to self‐reported questionnaires. This study evaluated the economic impact of introducing Plasmodium nucleic acid testing (NAT) as a universal screening strategy in the United States.
Cristina Coll‐Ortega, Elisabet Viayna, Jiani Zhou, Susan L. Stramer   +3 more
wiley   +1 more source

Precision Versus Non-Precision Oncology Drug Submissions to the National Centre for Pharmacoeconomics in Ireland

, 2022
Precision Versus Non-Precision Oncology Drug Submissions to the National Centre for Pharmacoeconomics in ...
Y Zhao (5839079), M Janodia (15833351), M Dimitrova (15833330), T Agh (15833315), S Kamat (15833333), M Hiligsmann (13500706), SH Hajimiri (15833348), C Daly (2909384), M Brzozowska (15833345), I Jakab (13448868), P Pednekar (15833321), B Borah (15833318), N Gangan (15833339), E Unni (15833342), J Zeber (15833324), G Milky (15833336), A Turcu-Stiolica (13506883), M Sharma (7759499), D Hutchinson (9657593), A Peterson (3577235), Elizabeth Manias (13068882), C Shah (29672), C Beaudart (13316355), S Atal (15833327)   +23 more
core  

Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in China

ClinicoEconomics and Outcomes Research
Wenjuan Wang,1,* Dachuang Zhou,1,* Kejia Zhou,1 Di Zhang,1 Hao Li,1 Hongliu Zhang,1 Xin Jiang,1 Ruihua Wang,1 Xi Wang,2 Wenxi Tang1 1Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, Jiangsu ...
Wang W, Zhou D, Zhou K, Zhang D, Li H, Zhang H, Jiang X, Wang R, Wang X, Tang W   +9 more
doaj  

ANALYSIS OF THE COST OF THE DISEASE — PROBLEMS AND SOLUTIONS

Педиатрическая фармакология, 2011
The article discusses the estimation of the disease value, which includes direct, indirect and «intangible» costs. Advantages and disadvantages of different approaches to cost accounting, including the method of direct costs microcalculation compared ...
V.V. Omel'yanovskii, M.V. Avksent'eva, E.V. Derkach, N.D. Sveshnikova   +3 more
doaj   +2 more sources

Global Landscape and Thematic Evolution of Selective GLP‐1 Receptor Agonists and GLP‐1–Based Multi‐Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Bibliometric analysis of 3736 publications (2004–2025) reveals rapid growth in GLP‐1–based T2DM research. The US leads, with Novo Nordisk and Eli Lilly as top contributors. Thematic shifts from glycemic control toward cardiovascular‐kidney‐metabolic outcomes and real‐world evidence, driven by landmark trials like LEADER and REWIND.
Yanbing Wang, Zhanru Liu, Shifeng Wang, Cuiyan Lv, Hesham R. El‐Seedi, Shaden A. M. Khalifa, Haiyan Wang   +6 more
wiley   +1 more source

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundWe examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM). Methods and ResultsWe conducted a cohort study of patients with
Eun Ha Kang, Yinzhu Jin, Gregory Brill, Jennifer Lewey, Elisabetta Patorno, Rishi J. Desai, Seoyoung C. Kim   +6 more
doaj   +1 more source

Patient‐Journey Mapping of CIDP Management in the Philippines: A Survey‐Informed Expert Panel Study and Recommendations From Treat CIDP Philippine Working Group

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Objectives To characterize real‐world barriers to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) management in the Philippines and identify pragmatic patient‐centered solutions aligned with international guidance and local health‐system realities. Methods We conducted a survey‐informed qualitative expert‐panel study involving
Raymond L. Rosales, Bibek Gyanwali, Mario B. Prado Jr, Ma. Geraldine S. Espiritu, Paul Matthew D. Pasco, Joh Aldwin Uy Co, Steven Gayoles Villaraza   +6 more
wiley   +1 more source

Pharmacoeconomics from the point of view of the interest groups

, 2011
This thesis deals with pharmacoeconomics and its application from the interest groups' active in the health care system point of view. Pharmacoeconomics is a relatively new scientific discipline, whose purpose is to facilitate the efficient allocation of
Pohlová, Martina
core